JACOB BARNEY: Open Payments
NPI 1295234755 · FIRTH, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,776 in 59 payments from 15 companies in 2025. Trend: 2023 $1,329 · 2024 $1,312 · 2025 $1,776
Food & beverage: $1,424Education: $177Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 16 | $585 |
| Janssen Biotech, Inc. | 13 | $345 |
| GlaxoSmithKline, LLC. | 6 | $177 |
| ABBVIE INC. | 6 | $161 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $130 |
| UCB, Inc. | 3 | $74 |
| Phathom Pharmaceuticals, Inc. | 1 | $63 |
| PFIZER INC. | 2 | $47 |
| ANI Pharmaceuticals, Inc. | 2 | $44 |
| Lilly USA, LLC | 2 | $42 |
Products named: TREMFYA, BENLYSTA, PROLIA, RINVOQ, TAVNEOS, KRYSTEXXA, CAPLYTA, OTEZLA.
Industry payments across ID — which companies pay providers there.
